Publication:
Evaluation of six commercial point-of-care tests for diagnosis of acute dengue infections: The need for combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of accuracy

dc.contributor.authorStuart D. Blacksellen_US
dc.contributor.authorRichard G. Jarmanen_US
dc.contributor.authorMark S. Baileyen_US
dc.contributor.authorAmpai Tanganuchitcharnchaien_US
dc.contributor.authorKemajittra Jenjaroenen_US
dc.contributor.authorRobert V. Gibbonsen_US
dc.contributor.authorDaniel H. Parisen_US
dc.contributor.authorRanjan Premaratnaen_US
dc.contributor.authorH. Janaka De Silvaen_US
dc.contributor.authorDavid G. Lallooen_US
dc.contributor.authorNicholas P J Dayen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherArmed Forces Research Institute of Medical Sciences, Thailanden_US
dc.contributor.otherRoyal Centre for Defence Medicineen_US
dc.contributor.otherUniversity of Kelaniyaen_US
dc.contributor.otherLiverpool School of Tropical Medicineen_US
dc.date.accessioned2018-05-03T07:58:57Z
dc.date.available2018-05-03T07:58:57Z
dc.date.issued2011-12-01en_US
dc.description.abstractSix assays were evaluated in this study to determine their suitability for the diagnosis of acute dengue infection using samples from 259 Sri Lankan patients with acute fevers (99 confirmed dengue cases and 160 patients with other confirmed acute febrile illnesses): (i) the Merlin dengue fever IgG & IgM combo device (Merlin), (ii) the Standard Diagnostics Dengue Duo nonstructural 1 (NS1) antigen and IgG/IgM combo device (Standard Diagnostics, South Korea), (iii) the Biosynex Immunoquick dengue fever IgG and IgM (Biosynex, France) assay, (iv) the Bio-Rad NS1 antigen strip (Bio-Rad, France), (v) the Panbio Dengue Duo IgG/IgM Cassette (Inverness, Australia), and (vi) the Panbio dengue NS1 antigen strip (Inverness, Australia). The median number of days of fever prior to admission sample collection was 5 days (interquartile range, 3 to 7 days). Sensitivity and specificity of the NS1 antigen tests ranged from 49 to 59% and from 93 to 99%, respectively, and sensitivity and sensitivity of the IgM antibody test ranged from 71 to 80% and from 46 to 90%, respectively. Combining the NS1 antigen and IgM antibody results from the Standard Diagnostics Dengue Duo test gave the best compromise of sensitivity and specificity (93% and 89%, respectively) and provided the best sensitivity in patients presenting at different times after fever onset. The Merlin IgM/IgG antibody tests correctly classified 64% and 86% of the primary and secondary dengue infection cases, respectively, and the Standard Diagnostics IgM/IgG antibody tests correctly classified 71% and 83% of the primary and secondary dengue infection cases, respectively. This study provides strong evidence of the value of combining dengue antigen- and antibody-based test results in the rapid diagnostic test (RDT) format for the acute diagnosis of dengue. Copyright © 2011, American Society for Microbiology. All Rights Reserved.en_US
dc.identifier.citationClinical and Vaccine Immunology. Vol.18, No.12 (2011), 2095-2101en_US
dc.identifier.doi10.1128/CVI.05285-11en_US
dc.identifier.issn1556679Xen_US
dc.identifier.issn15566811en_US
dc.identifier.other2-s2.0-83455259400en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/11424
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=83455259400&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleEvaluation of six commercial point-of-care tests for diagnosis of acute dengue infections: The need for combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of accuracyen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=83455259400&origin=inwarden_US

Files

Collections